市场调查报告书
商品编码
1399749
支气管镜市场 - 按产品类型(硬质支气管镜、柔性支气管镜)、按产品用途(一次性/一次性、可重复使用)、按年龄组(成人、儿童) - 全球预测,2023-2032 年Bronchoscopy Market - By Product Type (Rigid Bronchoscopes, Flexible Bronchoscopes), By Product Usage (Single Use/ Disposable, Reusable), By Age Group (Adult, Pediatric) - Global Forecast, 2023-2032 |
在技术不断发展的推动下,预计2023年至2032年支气管镜市场的CAGR将达到7.7%左右。虚拟支气管镜检查和支气管内超音波 (EBUS) 等先进成像模式的整合增强了支气管镜手术的诊断能力。这些程序使医疗保健专业人员能够以前所未有的精确度可视化和诊断呼吸系统疾病。
此外,肺癌和包括慢性阻塞性肺病(COPD)在内的呼吸系统疾病的盛行率激增,导致对支气管镜检查作为重要诊断和治疗工具的需求增加。根据 IARC 的资料,癌症是 2020 年的主要原因,导致近 180 万人死亡。近 85% 的肺癌病例是由吸烟引起的。
整个支气管镜市场根据产品类型、产品用途、年龄层和地区进行分类。
预计到2032 年,硬质支气管镜市场的产品需求将强劲。硬质支气管镜提供卓越的可视化效果并可进入下呼吸道,使其成为异物清除、支架置入和组织活检等复杂手术中不可或缺的一部分。随着医疗保健提供者寻求能够满足广泛患者病情的多功能仪器,硬性支气管镜在解决复杂的呼吸系统挑战方面的功效推动下,将实现持续增长。
预计到 2032 年,儿科领域将为市场带来巨额收入。患有呼吸道疾病的儿童需要独特的考虑,而支气管镜检查在诊断和治疗儿科气道疾病方面发挥关键作用。更小、更灵活的支气管镜的开发,加上儿科支气管镜的专门培训,正在促进对这一弱势患者群体进行更安全、更有效的手术。随着人们对早期介入益处的认识不断增强,儿科年龄组将推动产品需求。
由于医疗基础设施投资增加、人口老化加剧以及呼吸系统疾病负担增加等因素,亚太地区支气管镜产业将在 2032 年大幅成长。随着亚太地区医疗保健系统经历快速现代化,支气管镜市场预计将经历强劲成长,为製造商带来利润丰厚的机会。
The bronchoscopy market is predicted to record around 7.7% CAGR from 2023 to 2032 driven by the continuous evolution of technology. The integration of advanced imaging modalities, such as virtual bronchoscopy and endobronchial ultrasound (EBUS), enhances the diagnostic capabilities of bronchoscopy procedures. These procedures enable healthcare professionals to visualize and diagnose respiratory conditions with unprecedented precision.
Moreover, the surge in prevalence of lung cancer and respiratory disorders, including chronic obstructive pulmonary disease (COPD), has led to an increased demand for bronchoscopy as an essential diagnostic and therapeutic tool. According to the IARC data, cancer was a leading cause of death in 2020 amounting to nearly 1.8 million deaths. Nearly 85% of all lung cancer cases are caused by smoking.
The overall bronchoscopy market is classified based on product type, product usage, age group, and region.
The rigid bronchoscope segment is anticipated to record strong product demand through 2032. Rigid bronchoscopes offer superior visualization and access to the lower respiratory tract, making them indispensable for complex procedures such as foreign body removal, stent placement, and tissue biopsy. As healthcare providers seek versatile instruments that cater to a broad spectrum of patient conditions, rigid bronchoscopes are positioned for sustained growth, driven by its efficacy in addressing intricate respiratory challenges.
The pediatric segment is expected to generate massive revenues for the market by 2032. Children with respiratory issues require unique considerations, and bronchoscopy plays a pivotal role in diagnosing and treating pediatric airway disorders. The development of smaller and more flexible bronchoscopes, alongside dedicated training for pediatric bronchoscopy, is facilitating safer and more effective procedures in this vulnerable patient population. As awareness grows regarding the benefits of early intervention, the pediatric age group segment is will fuel the product demand.
Asia Pacific bronchoscopy industry will witness substantial growth through 2032 attributed by factors such as increasing healthcare infrastructure investments, a growing aging population, and a rising burden of respiratory diseases. As healthcare systems in Asia Pacific undergo rapid modernization, the bronchoscopy market is anticipated to experience robust growth, presenting lucrative opportunities for the manufacturers.